EarlySight's instrument is able to provide a ten times more precise image of the retina than the standard of care. Many ocular diseases (e.g. AMD, glaucoma) are starting with the degeneration of the retina cellular structure which is invisible to current examinations. Our instrument is able to observe and quantify the retinal cells. According to ophthalmologists, it will greatly improve the diagnosis and treatment follow-up by providing objective evidences of the disease progression.